Affiliation: Pfizer Global Research and Development
- A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placeboDahlia Garza
Pfizer Pharmaceuticals Inc, New York, New York 10017, USA
Biol Psychiatry 69:1075-82. 2011..There have been spontaneous postmarketing reports of neuropsychiatric adverse events (NPAEs) in smokers without a history of psychiatric illness quitting with varenicline...